Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HELP Study: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study to Evaluate DX-2930 For Long-Term Prophylaxis Against Acute Attacks of Hereditary Angioedema (HAE)

NCT02586805 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT02586805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02586805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HELP Study: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study to Evaluate DX-2930 For Long-Term Prophylaxis Against Acute Attacks of Hereditary Angioedema (HAE)
Lead sponsor
Shire
Phase
Phase 3
Overall status
Completed
Start date
March 3, 2016
Completion date
April 13, 2017
Enrollment
125 (actual)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary angioedema (hae)